Federal Court in Canada Upholds Pfizer’s Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010
Thursday, September 9th, 2010NEW YORK–(BUSINESS WIRE)–Pfizer Inc said today that the Canadian Federal Court has upheld a Pfizer patent covering amlodipine besylate, the active ingredient in Norvasc. The court issued (Source: Pfizer Media Center – News Releases)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.